a.batista
TL2 Moderator · Nantes
Contributes reviews on supplier material. Based in Nantes.
Joined 29 January 2025 · last posted 10d
76 posts, newest first. Showing up to 150.
-
Submitting a sample: the process end to end Replied, post #90 · Sourcing › Independent verification · 17 Jul 2026 · 21 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
Common supplements people ask about, assessed one at a time Replied, post #33 · Practice › Interactions · 11 Jul 2026 · 0 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #3 · Practice › Interactions · 1 Jul 2026 · 0 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
A pooled estimate that changed when one trial was added Replied, post #15 · Evidence › Meta-analyses · 27 Jun 2026 · 20 likes Publication bias: what did not get published? Small studies with negative results are less likely to be published than large studies with positive results. A forest…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #64 · Analytics › Home & field testing · 22 Jun 2026 · 4 likes What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #4 · Practice › Dosing & titration · 18 Jun 2026 · 0 likes I read post #2 twice before replying, because I had assumed the opposite. Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #25 · Start Here › Welcome · 16 Jun 2026 · 23 likes There is no stupid-questions rule and no penalty for asking badly. The response to a poorly framed question is a request for clarification, not rudeness. That is a…
-
Racemisation and why it is invisible to a mass measurement Replied, post #106 · Analytics › Impurities & related substances · 14 Jun 2026 · 0 likes post #105 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Semaglutide and alcohol: what is actually documented Replied, post #8 · Compounds › Semaglutide · 7 Jun 2026 · 21 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
-
Submitting a sample: the process end to end Replied, post #3 · Sourcing › Independent verification · 5 Jun 2026 · 0 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #23 · Compounds › Oral incretins · 5 Jun 2026 · 0 likes post #22 answers the question as asked. The question underneath it is different. Orforglipron is a small molecule, not a peptide. That changes almost everything: no…
-
Coming back to: When a red flag was a misunderstanding, and the retraction Replied, post #6 · Sourcing › Red flags · 31 May 2026 · 0 likes Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's verbal representation claiming a third, all on the same…
-
Follow-up: Search filters: what is missing Replied, post #114 · Meta › Site feedback · 29 May 2026 · 5 likes Moderation decisions: if you disagree with a moderation decision, raising it here gives it visibility. Staff will reconsider if you make a substantive case.
-
Dizziness on standing: the ordinary explanation first — one year on Replied, post #7 · Nutrition & Training › Hydration & electrolytes · 28 May 2026 · 19 likes Worth separating two things that post #3 runs together. Orthostatic symptoms: dizziness on standing after lying down can indicate dehydration or electrolyte depletion.…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #33 · Clinical › Comorbidities · 27 May 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Programming during a large energy deficit Replied, post #2 · Nutrition & Training › Resistance training · 19 May 2026 · 0 likes Frequency: three sessions per week of full-body training is easier to maintain than higher frequencies on an energy deficit. Consistency beats intensity when recovery…
-
A revision dispute resolved on the topic rather than in the history Replied, post #2 · Meta › Wiki maintenance · 7 May 2026 · 18 likes Revision disputes: if you disagree with an edit a maintainer made, discussing it here invites resolution rather than conflict.
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #14 · Analytics › Home & field testing · 29 Apr 2026 · 28 likes Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the result for the degraded sample, not for fresh material. That is…
-
The best-written scientific paper you have read Replied, post #5 · Lounge › Off topic · 14 Apr 2026 · 4 likes On the opening post — agreed on the reasoning, with one qualification. Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge…
-
Research-use-only status: what it means legally and practically Replied, post #25 · Compounds › Other compounds · 9 Apr 2026 · 0 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #3 · Research Methods › N-of-1 designs · 31 Mar 2026 · 0 likes Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the effect generalises to others similar to you, much less to people…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #101 · Research Methods › N-of-1 designs · 25 Mar 2026 · 33 likes When to run an n-of-1: this design works when you want to know whether a treatment works for you, not whether it works in general. For that purpose, it is efficient.
-
Oral semaglutide bioavailability and its variability between people Replied, post #43 · Compounds › Oral incretins · 21 Mar 2026 · 0 likes Picking up post #40: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #41 · Research Methods › N-of-1 designs · 10 Mar 2026 · 0 likes Washout periods: after stopping a medication, how long does it take for the effect to wash out? For compounds with a week-long half-life, roughly a month is needed to…
-
The lowest dose that does anything: is that a real question? Replied, post #75 · Practice › Dosing & titration · 6 Mar 2026 · 32 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
Grapefruit: why this class is not the class that cares Replied, post #11 · Practice › Interactions · 4 Mar 2026 · 8 likes Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
-
[2026 update] Availability by country, dated, with primary sources Replied, post #22 · Access › International · 5 Feb 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #49 · Documentation › Wiki requests · 22 Jan 2026 · 7 likes Correction requests: if you spot an error in a maintained page, note it here with the specific correction. The maintainer will review and update if justified.
-
Documentation that appears only after payment Replied, post #118 · Sourcing › Red flags · 26 Dec 2025 · 27 likes post #117 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
How to read a forest plot, properly, from scratch Replied, post #76 · Evidence › Trials · 26 Dec 2025 · 7 likes On post #72 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #13 · Pharmacology › Receptor biology · 15 Dec 2025 · 0 likes On post #9 — agreed on the reasoning, with one qualification. Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #49 · Clinical › Special populations · 10 Dec 2025 · 1 like On post #45 — agreed on the reasoning, with one qualification. Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #26 · Sourcing › Independent verification · 28 Nov 2025 · 20 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #15 · Practice › Reconstitution · 23 Nov 2025 · 5 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #10 · Compounds › Other compounds · 22 Nov 2025 · 25 likes I read post #8 twice before replying, because I had assumed the opposite. Compounds this community declines to help with, and why: there are specifics in the guidelines…
-
Follow-up: What a seizure notice actually says Replied, post #29 · Sourcing › Logistics · 26 Oct 2025 · 2 likes Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use and providing documentation (order, labelling) can help.…
-
Thyroid function tests during substantial weight change Replied, post #72 · Clinical › Bloodwork · 24 Sep 2025 · 6 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
Run-in periods and the population they select Replied, post #3 · Evidence › Trials · 21 Sep 2025 · 23 likes post #2 is right about the mechanism and I think understates the practical bit. Dropout is information: high dropout rates can indicate tolerability problems or lower…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #23 · Data & Tools › Datasets · 20 Sep 2025 · 19 likes Limitations of datasets: all community-collected data has limitations. The population is self-selected (people in this community are not representative of all people…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #63 · Evidence › Journal club · 9 Sep 2025 · 4 likes Coming back to post #61, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Asking about a compound your prescriber has not heard of Replied, post #145 · Clinical › Prescriber conversations · 1 Sep 2025 · 19 likes post #144 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Needle changes between doses on a reusable pen Replied, post #30 · Devices › Pens & autoinjectors · 24 Aug 2025 · 13 likes I read post #28 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #37 · Compounds › Secretagogues & GH axis · 18 Aug 2025 · 0 likes IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone level and it is still a surrogate, with all the caveats that come with surrogates.…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #75 · Compounds › Oral incretins · 2 Aug 2025 · 3 likes Fasting instructions are not optional advice. Taking the tablet with food or with more than a sip of water measurably reduces absorption. This is the one compound in…
-
A field-by-field walk through a certificate of analysis Replied, post #115 · Analytics › COA interpretation · 17 Jul 2025 · 1 like This follows post #112 rather than contradicting it. Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #32 · Clinical › Special populations · 30 Jun 2025 · 0 likes Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes monitoring for recurrence more important during titration.
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #63 · Evidence › Journal club · 25 Jun 2025 · 14 likes Picking up post #60: that is the part I would want checked first. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy.…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #110 · Access › Pricing · 22 May 2025 · 3 likes On post #106 — agreed on the reasoning, with one qualification. International pricing: the same compound costs very different amounts in different countries because…
-
A well-designed study with a badly written abstract Replied, post #94 · Evidence › Study critique · 20 May 2025 · 0 likes When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly. The critique might still be real but smaller than you…
-
[2026 update] Splitting an overlong document into two Replied, post #3 · Documentation › Wiki requests · 8 May 2025 · 15 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Metformin co-administration and additive GI effects Replied, post #28 · Practice › Interactions · 2 May 2025 · 32 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
Triple agonism: additive, synergistic, or neither? Replied, post #39 · Compounds › Retatrutide · 23 Apr 2025 · 32 likes post #38 answers the question as asked. The question underneath it is different. What we do not know about retatrutide, listed explicitly: long-term safety, real-world…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #36 · Evidence › Journal club · 18 Apr 2025 · 6 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #19 · Clinical › Comorbidities · 14 Apr 2025 · 26 likes Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN programmes established glycaemic benefit. The renal and…
-
Carryover and the ghost peak from last week's standard Replied, post #51 · Analytics › HPLC & UHPLC · 7 Apr 2025 · 6 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #6 · Devices › Pens & autoinjectors · 24 Mar 2025 · 4 likes This follows post #3 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #22 · Compounds › Cagrilintide & amylin analogues · 23 Mar 2025 · 0 likes I read post #20 twice before replying, because I had assumed the opposite. Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed…
-
Maintainer handover: how it works Replied, post #15 · Meta › Wiki maintenance · 13 Mar 2025 · 0 likes Worth separating two things that post #11 runs together. Maintainer handovers: if a page's maintainer is inactive and needs a new one, discussing that here can…
-
Residual solvents and scavengers: what is looked for Replied, post #3 · Analytics › Impurities & related substances · 11 Mar 2025 · 9 likes post #2 is right about the mechanism and I think understates the practical bit. Incomplete deprotection: mass higher by the protecting group mass. Usually markedly…
-
Washout: how long is long enough, and for what purpose Replied, post #4 · Pharmacology › Pharmacokinetics · 13 Feb 2025 · 3 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #71 · Analytics › COA interpretation · 28 Jan 2025 · 5 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #34 · Analytics › Mass spectrometry · 22 Jan 2025 · 22 likes Worth separating two things that post #30 runs together. Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass…
-
Follow-up: Individual participant data versus aggregate data Replied, post #33 · Evidence › Meta-analyses · 9 Jan 2025 · 18 likes This follows post #30 rather than contradicting it. Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are too…
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #31 · Practice › Interactions · 27 Nov 2024 · 0 likes Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #117 · Compounds › Repair & healing peptides · 22 Nov 2024 · 2 likes What would change the position on repair peptides: adequately powered, published, peer-reviewed randomised controlled human trials with pre-specified outcomes. That is…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #19 · Evidence › Journal club · 29 Oct 2024 · 1 like post #18 is right about the mechanism and I think understates the practical bit. SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #12 · Compounds › Cagrilintide & amylin analogues · 18 Oct 2024 · 0 likes Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined dose escalation. It does not establish the lowest effective…
-
Follow-up: Trifluoroacetate content and its consequences Replied, post #2 · Analytics › Impurities & related substances · 9 Oct 2024 · 7 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #48 · Analytics › Method validation · 9 Oct 2024 · 11 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #45 · Devices › Syringes & needles · 6 Oct 2024 · 20 likes Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer). Longer needles are needed for deeper tissue or if…
-
Levothyroxine timing: a real interaction with a simple fix Started this topic · Practice › Interactions · 29 Sep 2024 · 16 likes Levothyroxine timing: a real interaction with a simple fix Writing it up because I had to work it out twice and would rather nobody else did. Reporting something rather…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #55 · Compounds › Retatrutide · 23 Sep 2024 · 9 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #8 · Analytics › COA interpretation · 7 Aug 2024 · 11 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
-
Promotion criteria, and the one that stops most nominations Replied, post #21 · Documentation › Doc review · 20 Jul 2024 · 0 likes I read post #19 twice before replying, because I had assumed the opposite. Citation checking: if a maintained page cites a paper, the citation should match what the…
-
Two sessions a week versus four: what the evidence supports — a second dataset Replied, post #31 · Nutrition & Training › Resistance training · 12 Jul 2024 · 5 likes Volume: the number of sets per muscle group per week that supports muscle maintenance is roughly 12 to 18 hard sets. That varies by individual but gives a target range.
-
Assessing a warm arrival: the decision process — one year on Replied, post #25 · Sourcing › Logistics · 29 May 2024 · 0 likes Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…